Ruth Heaton

1.2k total citations · 1 hit paper
8 papers, 847 citations indexed

About

Ruth Heaton is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Ruth Heaton has authored 8 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Ruth Heaton's work include Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Ruth Heaton is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Ruth Heaton collaborates with scholars based in United States, United Kingdom and Japan. Ruth Heaton's co-authors include Alan F. List, Daruka Mahadevan, Lisa M. Rimsza, S. Kurtin, Deborah Fuchs, Jerome B. Zeldis, Denise J. Roe, Robert Knight, Betty Glinsmann‐Gibson and Robert L. Capizzi and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Ruth Heaton

8 papers receiving 809 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Lenalidomide in Myelodysplastic Syndromes

2005 613 citations Alan F. List, S. Kurtin et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth Heaton United States	5	684	337	284	108	79	8	847
S. Faderl United States	16	882 1.3×	417 1.2×	393 1.4×	240 2.2×	97 1.2×	24	1.2k
Deborah Fuchs United States	8	606 0.9×	368 1.1×	310 1.1×	101 0.9×	102 1.3×	20	882
Silke Soucek Germany	15	655 1.0×	379 1.1×	367 1.3×	225 2.1×	23 0.3×	21	985
Elisabeth Paietta United States	17	549 0.8×	309 0.9×	159 0.6×	114 1.1×	74 0.9×	26	751
S. Kurtin United States	3	554 0.8×	280 0.8×	250 0.9×	77 0.7×	71 0.9×	8	674
RA Kyle United States	12	540 0.8×	542 1.6×	163 0.6×	297 2.8×	44 0.6×	17	826
Paulo Lúcio Portugal	13	469 0.7×	255 0.8×	181 0.6×	160 1.5×	163 2.1×	30	854
Olga Salamero Spain	13	625 0.9×	381 1.1×	282 1.0×	167 1.5×	143 1.8×	46	890
Ryan J. Mattison United States	12	273 0.4×	238 0.7×	159 0.6×	111 1.0×	44 0.6×	58	518
B. Emmerich Germany	14	360 0.5×	254 0.8×	220 0.8×	183 1.7×	96 1.2×	39	733

Countries citing papers authored by Ruth Heaton

Since Specialization

Citations

This map shows the geographic impact of Ruth Heaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Heaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Heaton more than expected).

Fields of papers citing papers by Ruth Heaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Heaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Heaton. The network helps show where Ruth Heaton may publish in the future.

Co-authorship network of co-authors of Ruth Heaton

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Heaton. A scholar is included among the top collaborators of Ruth Heaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Heaton. Ruth Heaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

McGraw, Kathy L., Ashley A. Basiorka, Joseph Johnson, et al.. (2014). Lenalidomide Induces Lipid Raft Assembly to Enhance Erythropoietin Receptor Signaling in Myelodysplastic Syndrome Progenitors. PLoS ONE. 9(12). e114249–e114249. 21 indexed citations

2.

List, Alan F., S. Kurtin, Denise J. Roe, et al.. (2005). Efficacy of Lenalidomide in Myelodysplastic Syndromes. New England Journal of Medicine. 352(6). 549–557. 613 indexed citations breakdown →

3.

Gibson, Brenda, et al.. (2000). Thioredoxin is a novel redox-dependent cytokine that promotes in vitro growth of normal and myelodysplastic bone marrow progenitors. 1. 35516. 1 indexed citations

4.

List, Alan F., et al.. (1998). Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors. Leukemia. 12(10). 1596–1602. 52 indexed citations

5.

List, Alan F., et al.. (1997). Stimulation of Hematopoiesis by Amifostine in Patients With Myelodysplastic Syndrome. Blood. 90(9). 3364–3369. 99 indexed citations

6.

List, Alan F., et al.. (1997). 179 Promotion of multilineage hematopoiesis in patients with myelodysplastic syndrome: A phase I/II clinical trial with amifostine. Leukemia Research. 21(1). S47–S47. 3 indexed citations

7.

List, Alan F., Ruth Heaton, Betty Glinsmann‐Gibson, & Robert L. Capizzi. (1996). Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity.. PubMed. 23(4 Suppl 8). 58–63. 55 indexed citations

8.

Heaton, Ruth, et al.. (1988). The elastase: anti-elastase profile in lung lavage from sarcoidosis patients.. PubMed. 5(1). 31–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact